CN104491838A - 抗hpv病毒凝胶敷料及其制备方法 - Google Patents
抗hpv病毒凝胶敷料及其制备方法 Download PDFInfo
- Publication number
- CN104491838A CN104491838A CN201410798607.9A CN201410798607A CN104491838A CN 104491838 A CN104491838 A CN 104491838A CN 201410798607 A CN201410798607 A CN 201410798607A CN 104491838 A CN104491838 A CN 104491838A
- Authority
- CN
- China
- Prior art keywords
- hpv
- gel dressing
- hpv virus
- acid protein
- lyophilized powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 24
- 241000701806 Human papillomavirus Species 0.000 title abstract description 4
- 208000022361 Human papillomavirus infectious disease Diseases 0.000 claims abstract description 118
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 33
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 22
- 238000004108 freeze drying Methods 0.000 claims abstract description 19
- 206010008342 Cervix carcinoma Diseases 0.000 claims abstract description 15
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 claims abstract description 15
- 201000010881 cervical cancer Diseases 0.000 claims abstract description 15
- 230000009385 viral infection Effects 0.000 claims abstract description 15
- 239000000843 powder Substances 0.000 claims abstract description 14
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 13
- 210000004392 genitalia Anatomy 0.000 claims abstract description 13
- 206010008323 cervicitis Diseases 0.000 claims abstract description 11
- 201000003988 chronic cervicitis Diseases 0.000 claims abstract description 11
- 230000002265 prevention Effects 0.000 claims abstract description 10
- 230000000844 anti-bacterial effect Effects 0.000 claims abstract description 9
- 229910019142 PO4 Inorganic materials 0.000 claims abstract description 7
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims abstract description 7
- 239000010452 phosphate Substances 0.000 claims abstract description 7
- 101800000263 Acidic protein Proteins 0.000 claims abstract description 6
- 241000700605 Viruses Species 0.000 claims description 86
- 239000002253 acid Substances 0.000 claims description 42
- 108090000623 proteins and genes Proteins 0.000 claims description 42
- 102000004169 proteins and genes Human genes 0.000 claims description 42
- 239000008176 lyophilized powder Substances 0.000 claims description 33
- 239000006166 lysate Substances 0.000 claims description 19
- 244000269722 Thea sinensis Species 0.000 claims description 12
- 239000012043 crude product Substances 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 10
- 208000030940 penile carcinoma Diseases 0.000 claims description 9
- 201000008174 penis carcinoma Diseases 0.000 claims description 9
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 claims description 8
- 229960003260 chlorhexidine Drugs 0.000 claims description 8
- 150000004676 glycans Chemical class 0.000 claims description 8
- 229920001282 polysaccharide Polymers 0.000 claims description 8
- 239000005017 polysaccharide Substances 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 8
- 238000001291 vacuum drying Methods 0.000 claims description 8
- 239000000284 extract Substances 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 7
- 235000006468 Thea sinensis Nutrition 0.000 claims description 6
- 101710093543 Probable non-specific lipid-transfer protein Proteins 0.000 claims description 5
- 229920002684 Sepharose Polymers 0.000 claims description 5
- 238000005119 centrifugation Methods 0.000 claims description 5
- -1 fluidizer Substances 0.000 claims description 5
- 238000000227 grinding Methods 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 238000001556 precipitation Methods 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 5
- 239000006228 supernatant Substances 0.000 claims description 5
- 239000002562 thickening agent Substances 0.000 claims description 5
- 102000003886 Glycoproteins Human genes 0.000 claims description 3
- 108090000288 Glycoproteins Proteins 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 14
- 201000010099 disease Diseases 0.000 abstract description 9
- 208000009608 Papillomavirus Infections Diseases 0.000 abstract description 3
- 230000006870 function Effects 0.000 abstract description 2
- 210000001519 tissue Anatomy 0.000 abstract description 2
- 206010008263 Cervical dysplasia Diseases 0.000 abstract 2
- 208000007951 cervical intraepithelial neoplasia Diseases 0.000 abstract 2
- BLSQLHNBWJLIBQ-OZXSUGGESA-N (2R,4S)-terconazole Chemical compound C1CN(C(C)C)CCN1C(C=C1)=CC=C1OC[C@@H]1O[C@@](CN2N=CN=C2)(C=2C(=CC(Cl)=CC=2)Cl)OC1 BLSQLHNBWJLIBQ-OZXSUGGESA-N 0.000 abstract 1
- 208000032271 Malignant tumor of penis Diseases 0.000 abstract 1
- 235000006679 Mentha X verticillata Nutrition 0.000 abstract 1
- 235000002899 Mentha suaveolens Nutrition 0.000 abstract 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 abstract 1
- 208000002471 Penile Neoplasms Diseases 0.000 abstract 1
- 206010034299 Penile cancer Diseases 0.000 abstract 1
- 241001122767 Theaceae Species 0.000 abstract 1
- 239000000654 additive Substances 0.000 abstract 1
- 230000000996 additive effect Effects 0.000 abstract 1
- 239000003899 bactericide agent Substances 0.000 abstract 1
- 229940089256 fungistat Drugs 0.000 abstract 1
- 235000011187 glycerol Nutrition 0.000 abstract 1
- 210000004400 mucous membrane Anatomy 0.000 abstract 1
- 235000021317 phosphate Nutrition 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
- 235000018102 proteins Nutrition 0.000 description 32
- 239000003814 drug Substances 0.000 description 12
- 206010059313 Anogenital warts Diseases 0.000 description 9
- 230000003628 erosive effect Effects 0.000 description 7
- 240000008042 Zea mays Species 0.000 description 6
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 6
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 6
- 201000003505 cervical polyp Diseases 0.000 description 6
- 235000005822 corn Nutrition 0.000 description 6
- 208000036142 Viral infection Diseases 0.000 description 5
- 210000000270 basal cell Anatomy 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 210000001215 vagina Anatomy 0.000 description 5
- 210000003679 cervix uteri Anatomy 0.000 description 4
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 4
- 235000019796 monopotassium phosphate Nutrition 0.000 description 4
- 210000004877 mucosa Anatomy 0.000 description 4
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 4
- 210000002845 virion Anatomy 0.000 description 4
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 238000012797 qualification Methods 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 239000000829 suppository Substances 0.000 description 3
- 239000000003 vaginal tablet Substances 0.000 description 3
- 229940044977 vaginal tablet Drugs 0.000 description 3
- 108090000565 Capsid Proteins Proteins 0.000 description 2
- 102100023321 Ceruloplasmin Human genes 0.000 description 2
- 206010047786 Vulvovaginal discomfort Diseases 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000003013 cytotoxicity Effects 0.000 description 2
- 231100000135 cytotoxicity Toxicity 0.000 description 2
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 239000007938 effervescent tablet Substances 0.000 description 2
- 210000000981 epithelium Anatomy 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 210000004777 protein coat Anatomy 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 208000000907 Condylomata Acuminata Diseases 0.000 description 1
- 208000006313 Delayed Hypersensitivity Diseases 0.000 description 1
- 206010048461 Genital infection Diseases 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108010077850 Nuclear Localization Signals Proteins 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 206010040914 Skin reaction Diseases 0.000 description 1
- 206010046914 Vaginal infection Diseases 0.000 description 1
- 201000008100 Vaginitis Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 125000003275 alpha amino acid group Chemical group 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 210000003756 cervix mucus Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 210000004996 female reproductive system Anatomy 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 210000002445 nipple Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 208000015608 reproductive system cancer Diseases 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 230000035483 skin reaction Effects 0.000 description 1
- 231100000430 skin reaction Toxicity 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000029812 viral genome replication Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
Description
病例总数 | 痊愈例数 | 有效例数 | 无效例数 | |
试用组1 | 50 | 50 | 0 | 0 |
试用组2 | 50 | 50 | 0 | 0 |
试用组3 | 50 | 50 | 0 | 0 |
对照组 | 50 | 5 | 20 | 25 |
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410798607.9A CN104491838B (zh) | 2014-12-19 | 2014-12-19 | 抗hpv病毒凝胶敷料及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410798607.9A CN104491838B (zh) | 2014-12-19 | 2014-12-19 | 抗hpv病毒凝胶敷料及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104491838A true CN104491838A (zh) | 2015-04-08 |
CN104491838B CN104491838B (zh) | 2017-04-19 |
Family
ID=52933352
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410798607.9A Active CN104491838B (zh) | 2014-12-19 | 2014-12-19 | 抗hpv病毒凝胶敷料及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104491838B (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106177900A (zh) * | 2016-08-19 | 2016-12-07 | 吉安市御美丽健康产业股份有限公司 | 一种抗人乳头瘤病毒的凝胶及其制备方法 |
CN109821007A (zh) * | 2018-04-23 | 2019-05-31 | 海南海泽惠生物科技有限公司 | 苦瓜蛋白在制备抗人乳头瘤病毒感染药物中的应用 |
CN110478514A (zh) * | 2019-06-18 | 2019-11-22 | 广西信业生物技术有限公司 | 一种抗hpv病毒敷料及其制备方法 |
CN113730553A (zh) * | 2021-07-06 | 2021-12-03 | 江苏实干家生物科技有限公司 | 一种抗hpv病毒凝胶敷料及其制备方法 |
CN114767921A (zh) * | 2022-03-03 | 2022-07-22 | 吉林省国大生物工程有限公司 | 一种带负电荷抗hpv生物蛋白凝胶敷料的制备方法和应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102652778A (zh) * | 2012-03-29 | 2012-09-05 | 武汉华大药业有限公司 | 药物组合物 |
CN102908611A (zh) * | 2012-10-26 | 2013-02-06 | 太原锦波生物医药科技有限公司 | 一种预防和控制人乳头瘤病毒感染的生物蛋白敷料及隐形膜 |
CN103083472A (zh) * | 2013-01-25 | 2013-05-08 | 北海光谷纳米科技研发中心 | 一种治疗妇科炎症的纳米银抗炎凝胶及制备方法 |
-
2014
- 2014-12-19 CN CN201410798607.9A patent/CN104491838B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102652778A (zh) * | 2012-03-29 | 2012-09-05 | 武汉华大药业有限公司 | 药物组合物 |
CN102908611A (zh) * | 2012-10-26 | 2013-02-06 | 太原锦波生物医药科技有限公司 | 一种预防和控制人乳头瘤病毒感染的生物蛋白敷料及隐形膜 |
CN103083472A (zh) * | 2013-01-25 | 2013-05-08 | 北海光谷纳米科技研发中心 | 一种治疗妇科炎症的纳米银抗炎凝胶及制备方法 |
Non-Patent Citations (4)
Title |
---|
周裔彬: "茶多糖的纯化及结构分析", 《化学通报》 * |
徐仲溪: "茶多糖化学及生物活性的研究", 《茶叶科学》 * |
茶多糖化学及生物活性的研究;徐仲溪;《茶叶科学》;20040228;第24卷(第2期);75-81 * |
茶多糖的纯化及结构分析;周裔彬;《化学通报》;20080930(第9期);691-695 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106177900A (zh) * | 2016-08-19 | 2016-12-07 | 吉安市御美丽健康产业股份有限公司 | 一种抗人乳头瘤病毒的凝胶及其制备方法 |
CN109821007A (zh) * | 2018-04-23 | 2019-05-31 | 海南海泽惠生物科技有限公司 | 苦瓜蛋白在制备抗人乳头瘤病毒感染药物中的应用 |
CN109821007B (zh) * | 2018-04-23 | 2022-03-15 | 海南海泽惠生物科技有限公司 | 苦瓜蛋白在制备抗人乳头瘤病毒感染药物中的应用 |
CN110478514A (zh) * | 2019-06-18 | 2019-11-22 | 广西信业生物技术有限公司 | 一种抗hpv病毒敷料及其制备方法 |
CN113730553A (zh) * | 2021-07-06 | 2021-12-03 | 江苏实干家生物科技有限公司 | 一种抗hpv病毒凝胶敷料及其制备方法 |
CN114767921A (zh) * | 2022-03-03 | 2022-07-22 | 吉林省国大生物工程有限公司 | 一种带负电荷抗hpv生物蛋白凝胶敷料的制备方法和应用 |
Also Published As
Publication number | Publication date |
---|---|
CN104491838B (zh) | 2017-04-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104491838B (zh) | 抗hpv病毒凝胶敷料及其制备方法 | |
CN101406557A (zh) | 一种治疗烧伤、烫伤及多种皮肤损伤的外用中药 | |
CN104353058A (zh) | 商陆抗病毒蛋白冻干粉复合剂及其制备方法 | |
WO2013143412A1 (zh) | 药物组合物 | |
WO2020010919A1 (zh) | 一种中药组合物、中药复方制剂及其制备方法和应用 | |
WO2018137319A1 (zh) | 大叶清香桂的应用,治疗皮肤病的中药膏剂、制备方法及其应用 | |
CN113616714A (zh) | 一种高硒抗hpv病毒的生物蛋白凝胶敷料及其制备方法 | |
CN104173601B (zh) | 板蓝大青片及其制备方法 | |
CN104721234A (zh) | 美洲大蠊提取物离子敏感型原位凝胶及其制备方法 | |
JP2020528927A (ja) | ヒト乳頭腫ウイルスによる疾患を治療するための漢方薬組成物、その調製方法及び用途 | |
CN102028922B (zh) | 关节炎膏 | |
CN103191163B (zh) | 一种皮肤创面修复药物组合物 | |
CN103120727B (zh) | 一种治疗妇科炎症的中药组合物及其制备方法 | |
CN111759905A (zh) | 一种治疗骨关节炎的巴布剂及其制备方法 | |
CN101829188B (zh) | 一种治疗泌尿系感染和结石病的药物 | |
CN104706914B (zh) | 一种治疗细菌性阴道炎的中药及制备方法 | |
CN101612203A (zh) | 一种用于治疗尖锐湿疣的中药组合物及其应用 | |
CN103386101A (zh) | 一种治疗非特异性膀胱炎的中药制剂及其制备方法 | |
CN103181964B (zh) | 治疗动物体表创伤的中药组合物及其制备方法 | |
CN107970381A (zh) | 一种化痰的宣木瓜茶及其制备方法和应用 | |
CN107551174A (zh) | 一种治疗宫颈hpv感染的外用中药及其制备方法 | |
CN110064003B (zh) | 一种治疗带状疱疹的中药组合物及其制备方法 | |
CN106924326A (zh) | 一种横根费菜提取物及其制备方法和用途 | |
CN104873654A (zh) | 一种用于治疗荨麻疹的药物制剂 | |
CN116421705A (zh) | 降低宫颈癌发病风险的药物制剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20191030 Address after: 225300 No. 6 Yuzhu Road, Taizhou Medical High-tech Zone, Jiangsu Province Patentee after: JIANGSU SR-BIOPHARMA BIOLOGICAL PHARMACEUTICAL CO.,LTD. Address before: The national high tech Industrial Park in Hainan province Haikou trough road 570000 No. 5 Patentee before: HAINAN SR-BIOPHARMA CO.,LTD. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200317 Address after: The national high tech Industrial Park in Hainan province Haikou trough road 570000 No. 5 Patentee after: HAINAN SR-BIOPHARMA Co.,Ltd. Address before: 225300 No. 6 Yuzhu Road, Taizhou Medical High-tech Zone, Jiangsu Province Patentee before: JIANGSU SR-BIOPHARMA BIOLOGICAL PHARMACEUTICAL Co.,Ltd. |
|
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: No. 5 Yaogu 1st Road, National High tech Industrial Park, Haikou City, Hainan Province, 570311 Patentee after: Senruipu Life Science Pharmaceutical (Hainan) Group Co.,Ltd. Address before: 570000 No.5, Yaogu 1st Road, national high tech Industrial Park, Haikou City, Hainan Province Patentee before: HAINAN SR-BIOPHARMA CO.,LTD. |